Kirov Hristo, Caldonazo Tulio, Woehlecke Herrmann, Fazini Luca, Fischer Johannes, Costa Vlander, Amorim Paulo, Runkel Angelique, Rodrigues Eduardo, Mukharyamov Murat, de Sá Mauro P L, Doenst Torsten
Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Germany.
Department of Medical Sciences and Public Health, Clinical Cardiology Unit, University of Cagliari, Cagliari, Italy.
Am Heart J Plus. 2025 Sep 13;59:100606. doi: 10.1016/j.ahjo.2025.100606. eCollection 2025 Nov.
There is controversy on the effect of percutaneous coronary intervention (PCI) on outcomes of patients undergoing coronary artery bypass grafting (CABG). We meta-analytically assessed the prognostic impact of prior PCI in patients with coronary artery disease (CAD) who underwent CABG.
We performed a systematic review and meta-analysis of studies comparing patients who underwent CABG and had prior PCI in the past with patients who underwent CABG as primary treatment of CAD. Three databases were assessed. The primary endpoint was perioperative mortality. The secondary outcomes were long-term survival, perioperative myocardial infarction, neurological events, bleeding, acute renal failure, and hospital length of stay. Reconstruction of time-to-event data and pairwise meta-analysis were performed.
Nineteen studies met the criteria for inclusion in the final analysis. Risk of perioperative mortality in patients undergoing CABG after a prior PCI was higher than in those undergoing primary CABG (OR: 1.16, 95 % CI, 1.03-1.31, = 0.02). However, the prior PCI group presented higher survival rates when compared to the primary CABG group over the entire follow-up (HR: 0.90, 95 % CI, 0.86-0.94, < 0.01). There was no significant difference between the groups regarding the other secondary outcomes.
When compared with patients who underwent CABG as primary treatment of CAD, prior PCI is associated with higher perioperative mortality for patients undergoing CABG. However, this increase in perioperative risk does not correlate with a decrease in long-term survival.
经皮冠状动脉介入治疗(PCI)对接受冠状动脉旁路移植术(CABG)患者预后的影响存在争议。我们进行了荟萃分析,以评估既往接受PCI的冠心病(CAD)患者在接受CABG时的预后影响。
我们对比较既往接受过PCI并接受CABG的患者与接受CABG作为CAD主要治疗方法的患者的研究进行了系统评价和荟萃分析。评估了三个数据库。主要终点是围手术期死亡率。次要结局包括长期生存率、围手术期心肌梗死、神经系统事件、出血、急性肾衰竭和住院时间。进行了事件发生时间数据的重建和成对荟萃分析。
19项研究符合纳入最终分析的标准。既往接受过PCI的患者在接受CABG后的围手术期死亡风险高于接受初次CABG的患者(OR:1.16,95%CI,1.03 - 1.31,P = 0.02)。然而,在整个随访期间,既往接受PCI组的生存率高于初次CABG组(HR:0.90,95%CI,0.86 - 0.94,P < 0.01)。两组在其他次要结局方面无显著差异。
与接受CABG作为CAD主要治疗方法的患者相比,既往接受PCI的患者在接受CABG时围手术期死亡率更高。然而,围手术期风险的增加与长期生存率的降低无关。